EN
HI

METROPOLIS HEALTHCARE Share price

METROPOLIS

HealthcareMid

1684

16.40 (-0.96%)
NSE
BSE
Last updated on 6 May, 2025 | 15:42 IST
BUYSELL
Today's High

1671.60

Today's Low

1717.40

52 Week Low

2318.30

52 Week High

2318.30

The current prices are delayed, login to your account for live prices

Metropolis Healthcare Chart

METROPOLIS HEALTHCARE Share Key Metrics

Volume
52916.00
Market Cap
8635.74 CR
LTQ@LTP
1@1684.00
ATP
1686.11
Var Margin
1531
Circuit Range
1360.4-2040.4
Delivery %
35.28
Value
8.92 CR
ASM/GSM
No
Market Lot
1

METROPOLIS HEALTHCARE Futures & Options

Data Not Found

METROPOLIS HEALTHCARE Corporate Actions

DateAgenda
2025-02-04Quarterly Results
DateEvent TypeAgenda
2025-02-04Board MeetingQuarterly Results

METROPOLIS HEALTHCARE News

Metropolis Healthcare to acquire Core Diagnostics for Rs 247 cr

Dec 09 2024 19:26:50
Read More

About METROPOLIS HEALTHCARE

NSE : 9581  
BSE : 542650  
ISIN : INE112L01020  

Dr. Sushil Kanubhai Shah one of The Promoters commenced pathology business in January 1980 as a partnership firm in the name of Dr. V. K. Desai’s Hospital having Dr. Kanubhai M. Shah Dr. Sushil Kanubhai Shah and Dr. Vasant Kalyandas Desai as partners. The partnership was continued by Dr. Sushil Kanubhai Shah Dr. Kanubhai M. Shah and Dr. Duru Sushil Shah from September 30 1981 onwards. In June 1989 upon death of Dr. Kanubhai M. Shah the partnership was continued by Dr. Sushil Kanubhai Shah and Dr. Duru Sushil Shah. Prior to March 18 1995 Dr. Sushil Kanubhai Shah was also carrying on a business of radioimmunoassay and pathology laboratory on a sole proprietorship basis. On March 20 1995 the said sole proprietorship business was converted into a partnership with Dr. Sushil Kanubhai Shah Dr. Duru Sushil Shah and Aparna S. Shah (Rajadhyaksha) as partners in the name and style of Metropolis Lab. In January 1998 Ameera Sushil Shah was inducted as an additional partner in Metropolis Lab. With effect from February 1 2002 the business of Metropolis Lab was transferred to Dr. V. K. Desai’s Hospital as a going concern. In May 2002 Dr. G. S. K. Velu and Subbulakshmi K. Velu were admitted as partners in Dr. V. K. Desai Hospitals. The name of Dr. V. K. Desai’s Hospital was changed to Metropolis Health Services in November 2002. Further in April 2003 Ameera Sushil Shah Jaswanti Kanubhai Shah Sadacharan Gomanthybabu and Gomathybabu Gomathy were admitted as partners in Metropolis Health Services.In July 2003 Metropolis Health Services was converted into a private limited company as Metropolis Health Services (India) Private Limited (“MHSIPL”) under the Companies Act 1956. The name of MHSIPL was changed to Metropolis Health Services (India) Limited (“MHSIL”) pursuant to a ‘Fresh Certificate of Incorporation Consequent upon Change of Name on Conversion to Public Limited Company’ granted by RoC on March 1 2006. In January 2009 MHSIL amalgamated with Pathnet India Private Limited which was a wholly owned subsidiary of MHSIL. For details see “– Scheme of amalgamation between Pathnet India Private Limited and Metropolis Health Services (India) Limited Metro Home Health Services Private Limited Lister Metropolis Laboratory and Research Centre Private Limited Tripoli Path Lab Private Limited and Diwanchand Metropolis Diagnostics Services Private Limited”.Pathnet India Private Limited was incorporated at New Delhi as a private limited company under the Companies Act 1956 pursuant to the ‘Certificate of Incorporation’ granted by the Registrar of Companies N. C. T. of Delhi and Haryana on November 10 2000. The name of The Company was changed to Pathnet India Limited pursuant to a ‘Fresh Certificate of Incorporation Consequent upon Change of Name on Conversion to Public Limited Company’ granted by RoC on July 1 2009. The name of The Company was changed to Metropolis Healthcare Limited pursuant to a ‘Fresh Certificate of Incorporation Consequent upon Change of Name’ granted by RoC on September 23 2009. Major events and milestones of The Company :2002-First major acquisition by the Company of Sudharma2004-The Company was accredited by National Accreditation Board for Testing and Calibration Laboratories (Department of Science & Technology India)2005-The Company received accreditation from The College of American Pathologists2006-Investment by The Western India Trustee and Executor Company in the Company-Acquisition of M/s. Lister Laboratory and Research Centre Private Limited in Chennai2007-Acquisition of Desai Clinical Laboratory in Surat2008-Acquisition of R.V Diagnostics & Healthcare Center Private Limited in Bangalore2009-Scheme of Amalgamation 20092010-Investment by Foxcreek Investment Limited in the Company2011-Acquisition of LabOne in Raipur2012-Acquisition of Micron Laboratories in Mumbai-Acquisition of subsidiary in Kenya-Acquisition of Dr. Patel Pathology Laboratory Private Limited in Nashik-Incorporation of subsidiary in Mauritius2013-Acquisition of M/s. Ekopath Center-Pathology and Cytology Division in Guwahati-Establishment of GRL in Mumbai2014-Acquisition of subsidiary in Ghana2015-Investment by CA Lotus Investments in the Company-Incorporation of subsidiary in Uganda-Incorporation of branch office in Zambia2017-Acquisition of Sanjeevani Pathology Laboratory in Rajkot2018-Public-Private partnership agreement executed with National AIDS Control Organisation Government of India-Scheme of Amalgamation 2018-Incorporation of subsidiary in Tanzania  Awards achievements and certifications :2010-The Company was awarded the “Diagnostic Services Company of the Year” by Frost & Sullivan2012-The Company was felicitated for providing “Outstanding Quality Diagnostic Services” by HIV Congress 20122014-The Company was awarded the “Most Promising Brand” by the World Consulting and Research Corporation-The Company was awarded as a “Quality Brand” by Quality Brands India2015-The Company was awarded the “Best Diagnostic Company of the Year” at the National Awards for Excellence in Healthcare 2015-The Company was awarded the “Diagnostic Services Company of the Year” by the VCCircle Network-The Company was awarded for “Excellence in Productive Employment Creation” by Business Today2018-The Company was awarded for “Best in Health and Fitness” in the Digital Campaign Awards by LH Insights-The Company was awarded for “Excellence in Customer Service & Delivery” by Biotrains-The Company was awarded special jury mention for “Service Excellence (Diagnostic Centre)” by FICCI at the Healthcare Excellence Awards2018-2019-The Company was awarded “Iconic Pathology Lab Mumbai” by Midday Health & Wellness Icons

METROPOLIS HEALTHCARE Management

NamePosition
Dr. Sushil Kanubhai Shah Chairman & Executive Director
Mrs. Ameera Sushil Shah Managing Director
Mr. Hemant Sachdev Non Exe.Non Ind.Director
Mr. Vivek Gambhir Independent Director
Mr. Sanjay Bhatnagar Independent Director
Read More

METROPOLIS HEALTHCARE FAQs

The Buying Price of METROPOLIS HEALTHCARE share is 1337.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy METROPOLIS HEALTHCARE share to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of METROPOLIS HEALTHCARE shares is 65.73. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio METROPOLIS HEALTHCARE shares is 7.7. Useful to assess the stock's value relative to its book value.

To assess METROPOLIS HEALTHCARE’s valuation compare Sector P/E, P/B which are 43.04 & 3.34 with sector averages, along with growth rates and financial metrics.

The Market Cap of METROPOLIS HEALTHCARE is 8635.74 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of METROPOLIS HEALTHCARE share price is 2318.30 & 1315.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.